|
||||||||||||||||||||||||||||||||
|
> submit story or ask questions
> create account > FAQ > Early Years > Successful Businessman > M.P. – Lok Sabha > Railways Minister > Family & Friends > Tourism & Culture > Sports > Business & Industry > Defence > Development
Login
Membership has its privileges. Choose a username and provide a working email - that's all it takes to join. Click below to make a new account. Make a new account |
Mashelkar stresses on funding for BT
Section Investment Pune Posted on Sun Jan 14, 2007 at 08:24:45 AM EST
Talking at Hi-Tech Pune, CSIR director general also lays emphasis on single regulator for sector
As seen in other parts of the world, biotechnology has immense growth potential in India, but for new companies making a foray into the sector, there is hardly any seed funding available.
To address this gap, the government will soon set up a fund to finance start ups in the biotechnology sector.
Mashelkar also traced issues related to the sector in the country. "Our future is bright in biotechnology as both central and certain state governments are upbeat about the possibilities in the sector. But there are certain concerns, which will have to be addressed so as to have an edge in the international biotechnology scene,'' he said.
On the controversies relating to Genetically Modified (GM) crops, Mashelkar said the policy on the matter has to be reviewed. "Globally, it is seen that governments either take a permissive or preventive stand on the issue. The correct approach is to strike a balance between them. It is imperative that in sectors like agri-biotechnology, GM crops will be required,'' he said.
According to him, developing countries were taking a lead in switching over to GM crops. "10 years ago, eight per cent of the developing countries had GM crops, but now, the number is as high as 34 per-cent,'' he said. In fact, with 7.2 million hectares under cultivation of GM crops, developing countries have overtaken developed countries, which have 6.1 million hectares under GM crops. He also said that unlike IT, there was hardly any hue and cry over companies shifting their operations to the Asia Pacific region. "This shifting will reduce costs of medicines and biotechnology products, which will ultimately benefit every one,'' Mashelkar said. Source: Expressindia.com
Mashelkar stresses on funding for BT | 0 comments (0 topical, 0 hidden)
|
| All trademarks and copyrights on this page are owned by their respective companies. Comments are owned by the Poster. The Rest (c) 2004 skalmadi.org and QBTPL, Gurgaon. |